Here, beyond demonstrating that EBF1 is an Ikaros target, we also provided strong lines of evidence that Ikaros deletion directly reduces activation of EBF1 in leukemia cells contributing to an extensive block of B-cell differentiation. The gene discussed is EBF1; the disease is leukemia.